The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MAIA Biotechnology Inc shares valued at $50,000 were purchased by Guerrero Ramiro on Mar 03 ’25. At $1.50 per share, Guerrero Ramiro acquired 33,333 shares. The insider’s holdings grew to 568,218 shares worth approximately $1.0 million following the completion of this transaction.
Also, Smith Stan purchased 25,000 shares, netting a total of over 37,500 in proceeds. Following the buying of shares at $1.50 each, the insider now holds 1,205,060 shares.
Before that, Guerrero Ramiro had added 73,333 shares to its account. In a trade valued at $110,000, the Director bought MAIA Biotechnology Inc shares for $1.50 each. Upon closing the transaction, the insider’s holdings increased to 73,333 shares, worth approximately $0.94 million.
Analyzing MAIA Stock Performance
During the last five days, there has been a surge of approximately 11.39%. Over the course of the year, MAIA Biotechnology Inc shares have dropped approximately -11.11%. Shares of the company reached a 52-week high of $2.5500 on 01/07/25 and a 52-week low of $1.4600 on 03/11/25. A 50-day SMA is recorded $1.8649, while a 200-day SMA reached $2.6084.
Support And Resistance Levels for MAIA Biotechnology Inc (MAIA)
According to the 24-hour chart, there is a support level at 1.6771, which, if violated, would cause prices to drop to 1.5943. In the upper region, resistance lies at 1.8964. The next price resistance is at 2.0329. RSI (Relative Strength Index) is 51.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0745, which suggests the price will decrease in the coming days. Percent R is at 38.78%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
